Comparing the effects of tofacitinib, methotrexate and the combination, on bone marrow oedema, synovitis and bone erosion in methotrexate-naive, early active rheumatoid arthritis: results of an exploratory randomised MRI study incorporating semiquantitative and quantitative techniques

OBJECTIVES: To explore the effects of tofacitinib—an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA)—with or without methotrexate (MTX), on MRI endpoints in MTX-naive adult patients with early active RA and synovitis in an index wrist or hand. METHODS: In this exploratory,...

Descripción completa

Detalles Bibliográficos
Autores principales: Conaghan, Philip G, Østergaard, Mikkel, Bowes, Michael A, Wu, Chunying, Fuerst, Thomas, van der Heijde, Désirée, Irazoque-Palazuelos, Fedra, Soto-Raices, Oscar, Hrycaj, Pawel, Xie, Zhiyong, Zhang, Richard, Wyman, Bradley T, Bradley, John D, Soma, Koshika, Wilkinson, Bethanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893111/
https://www.ncbi.nlm.nih.gov/pubmed/27002108
http://dx.doi.org/10.1136/annrheumdis-2015-208267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893111/
https://www.ncbi.nlm.nih.gov/pubmed/27002108
http://dx.doi.org/10.1136/annrheumdis-2015-208267

Ejemplares similares